Who are Purified Cortophin Gel 80 U's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Purified Cortophin Gel, 40 U.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/purified-cortophin-gel-80-u.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Purified Cortophin Gel 80 U — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Purified Cortophin Gel 80 U (Purified Cortophin Gel 80 U) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ACTH analog / corticotropin. Area: Immunology / Rheumatology.

marketed ACTH analog / corticotropin Melanocortin-2 receptor (MC2R) Immunology / Rheumatology Small molecule Live · refreshed every 30 min

Target snapshot

Purified Cortophin Gel 80 U (Purified Cortophin Gel 80 U) — Massachusetts General Hospital. Purified Cortophin Gel is a repository formulation of adrenocorticotropic hormone (ACTH) that stimulates the adrenal cortex to produce and release endogenous corticosteroids.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Purified Cortophin Gel 80 U TARGET	Purified Cortophin Gel 80 U	Massachusetts General Hospital	marketed	ACTH analog / corticotropin	Melanocortin-2 receptor (MC2R)
Purified Cortophin Gel, 40 U	Purified Cortophin Gel, 40 U	Massachusetts General Hospital	marketed	ACTH analog / corticotropin	Melanocortin-2 receptor (MC2R)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ACTH analog / corticotropin class)

Massachusetts General Hospital · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Purified Cortophin Gel 80 U — Competitive Intelligence Brief. https://druglandscape.com/ci/purified-cortophin-gel-80-u. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab